2025 International Conference Day Three Afternoon: Representatives of companies such as Novartis, Roche, and Bayer entered the venue.

Caixinshe reporters learned from the on-site negotiations of the 2025 National Medical Insurance Catalogue and the Commercial Insurance Innovation Drug Catalogue that the afternoon session of the 2025 national negotiations started at around 13:40 on the third day, with companies including Novartis, Glaxo, Roche, and Bayer Pharmaceuticals. According to on-site observations, the focus of today's negotiations in the morning was on chronic disease drugs, including antidiabetic drugs. Companies such as Lilly and Yunnuo Pharmaceuticals brought heavyweight products to the negotiations.